Onbrez

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
012320102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Indacaterol, as well glycopyronium has been reimbursed lately in Poland, so patients have a greater access to this treatment in… (More)
Is this relevant?
2017
2017
BACKGROUND Inhaled indacaterol (Onbrez Breezhaler), a long-acting β2-agonist, is approved in over 100 countries, including South… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2012
2012
  • Perspective infirmiere : revue officielle de l…
  • 2012
 
Is this relevant?
2011
2011
 
Is this relevant?
Review
2010
Review
2010
Indacaterol (Onbrez), previously known as QAB-149-AFA, is a novel ultra-long-acting beta2-adrenoceptor agonist that was recently… (More)
Is this relevant?
Review
2010
Review
2010
  • R A Mcivor
  • Polskie Archiwum Medycyny Wewnetrznej
  • 2010
381 Chronic obstructive pulmonary disease (COPD) is a progressive, life‐threatening respiratory disease that affects 210 million… (More)
Is this relevant?